A STAT3-based gene signature stratifies glioma patients for targeted therapy

STAT3 activates distinct transcriptional programmes within cancer cells. In this study, the authors find that, in glioma, a STAT3-mediated expression signature can stratify patients for targeted precision therapy.

Bibliographic Details
Main Authors: Melanie Si Yan Tan, Edwin Sandanaraj, Yuk Kien Chong, See Wee Lim, Lynnette Wei Hsien Koh, Wai Hoe Ng, Nguan Soon Tan, Patrick Tan, Beng Ti Ang, Carol Tang
Format: Article
Language:English
Published: Nature Portfolio 2019-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-11614-x
_version_ 1818842085461065728
author Melanie Si Yan Tan
Edwin Sandanaraj
Yuk Kien Chong
See Wee Lim
Lynnette Wei Hsien Koh
Wai Hoe Ng
Nguan Soon Tan
Patrick Tan
Beng Ti Ang
Carol Tang
author_facet Melanie Si Yan Tan
Edwin Sandanaraj
Yuk Kien Chong
See Wee Lim
Lynnette Wei Hsien Koh
Wai Hoe Ng
Nguan Soon Tan
Patrick Tan
Beng Ti Ang
Carol Tang
author_sort Melanie Si Yan Tan
collection DOAJ
description STAT3 activates distinct transcriptional programmes within cancer cells. In this study, the authors find that, in glioma, a STAT3-mediated expression signature can stratify patients for targeted precision therapy.
first_indexed 2024-12-19T04:36:22Z
format Article
id doaj.art-d61c46f20a3c44179f855b1383771751
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-19T04:36:22Z
publishDate 2019-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-d61c46f20a3c44179f855b13837717512022-12-21T20:35:44ZengNature PortfolioNature Communications2041-17232019-08-0110111510.1038/s41467-019-11614-xA STAT3-based gene signature stratifies glioma patients for targeted therapyMelanie Si Yan Tan0Edwin Sandanaraj1Yuk Kien Chong2See Wee Lim3Lynnette Wei Hsien Koh4Wai Hoe Ng5Nguan Soon Tan6Patrick Tan7Beng Ti Ang8Carol Tang9Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteNeuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteNeuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteNeuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteNeuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteDepartment of Neurosurgery, National Neuroscience InstituteSchool of Biological Sciences, Nanyang Technological UniversityDuke-National University of Singapore Medical SchoolSingapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR)Neuro-Oncology Research Laboratory, Department of Research, National Neuroscience InstituteSTAT3 activates distinct transcriptional programmes within cancer cells. In this study, the authors find that, in glioma, a STAT3-mediated expression signature can stratify patients for targeted precision therapy.https://doi.org/10.1038/s41467-019-11614-x
spellingShingle Melanie Si Yan Tan
Edwin Sandanaraj
Yuk Kien Chong
See Wee Lim
Lynnette Wei Hsien Koh
Wai Hoe Ng
Nguan Soon Tan
Patrick Tan
Beng Ti Ang
Carol Tang
A STAT3-based gene signature stratifies glioma patients for targeted therapy
Nature Communications
title A STAT3-based gene signature stratifies glioma patients for targeted therapy
title_full A STAT3-based gene signature stratifies glioma patients for targeted therapy
title_fullStr A STAT3-based gene signature stratifies glioma patients for targeted therapy
title_full_unstemmed A STAT3-based gene signature stratifies glioma patients for targeted therapy
title_short A STAT3-based gene signature stratifies glioma patients for targeted therapy
title_sort stat3 based gene signature stratifies glioma patients for targeted therapy
url https://doi.org/10.1038/s41467-019-11614-x
work_keys_str_mv AT melaniesiyantan astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT edwinsandanaraj astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT yukkienchong astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT seeweelim astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT lynnetteweihsienkoh astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT waihoeng astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT nguansoontan astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT patricktan astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT bengtiang astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT caroltang astat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT melaniesiyantan stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT edwinsandanaraj stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT yukkienchong stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT seeweelim stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT lynnetteweihsienkoh stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT waihoeng stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT nguansoontan stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT patricktan stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT bengtiang stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy
AT caroltang stat3basedgenesignaturestratifiesgliomapatientsfortargetedtherapy